Promotions & Moves

Regis Technologies Appoints Tadgh Prendeville as President, CEO

Tadgh brings broad experience, proven history of delivering solutions to customers and excellent leadership skills.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Regis Technologies, Inc. has appointed Tadgh Prendeville as the new President and CEO of the company. Tadgh succeeds Louis Glunz, IV.    Prendeville joins the company from ARx LLC, a family-owned CMDO where served as President. He is an experienced leader, having helped deliver five FDA approvals through innovative pharmaceutical development at ARx LLC. “We are delighted to welcome Tadgh to Regis. His broad experience, proven history of delivering solutions to customers and excellen...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters